Back

Is downtitration of diuretic therapy safe in patients with heart failure?

20 May 2023 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: Chronic heart failure - pharmacotherapy 1 Pharmacotherapy HFA Premium Access Heart Failure 2023 Heart Failure Association (HFA)

About the speaker

Photo
Mr Chrit Geraeds

Maastricht University Medical Center+, Maastricht (Netherlands (The))

6 More presentations in this session

Presentation thumbnail
Pharmacologic transition in the care of patients with heart failure with reduced ejection fraction - a real life analysis
Doctor I. Cruz (Penafiel, PT)
Abstract Slides
Presentation thumbnail
Assessing the achievability of optimal therapy in patients with heart failure with reduced ejection fraction; a difficult task?
Miss F. Bernier (Quebec, CA)
Abstract Slides
Presentation thumbnail
Risk of safety events considered potential barriers to utilization of guideline-directed medical therapy among patients with worsening heart failure and ejection fraction 30% or lower
Doctor S. Greene (Durham, US)
Abstract Slides
Presentation thumbnail
Clinical outcomes in patients with ischemic versus non-ischemic cardiomyopathy after angiotensin-neprilysin inhibition therapy
Doctor C. Sabanoglu (Ankara, TR)
Abstract Slides
Presentation thumbnail
Five-year retrospective analysis of treatment efficacy effectiveness of sacubitril/valsartan in heart failure with reduced ejection fraction with end-stage renal disease
Doctor B. Hsiao (Taipei, TW)
Abstract Slides

Access the full session

Session thumbnail
Chronic heart failure - pharmacotherapy 1

The Event

Event poster

Heart Failure 2023

20 May - 23 May 2023
You may be interested in
thumbnail
Congress Session
Guideline-directed medical therapy implementation in special clinical scenarios
thumbnail
Congress Presentation
Audience Q&A
thumbnail
Congress Presentation
Did we forget ARNI in the era of SGLTi?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources